SCHEMBL2206447

SCHEMBL2206447

CN1CCN(C)C1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL357692 0.96
Bromide SCHEMBL4651773 0.96
Iodide SCHEMBL7216934 0.96
Hydrochloric Acid SCHEMBL265340 0.96
Methylene Chloride SCHEMBL4462021 0.87
SCHEMBL23716908 0.86
Hydrochloric Acid SCHEMBL10830067 0.83
SCHEMBL5744333 0.81
SCHEMBL10515763 0.74
SCHEMBL11101962 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3087093-B1 PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES STEALTH BIOTHERAPEUTICS CORP (MC) 2021-11-10 EP claimed
CN-112457368-A Pharmaceutically-related aromatic-cationic peptides 康德生物医疗技术公司 2021-03-09 CN claimed
CN-106132984-B Pharmaceutically-related aromatic-cationic peptides 康德生物医疗技术公司 2020-12-08 CN claimed
EP-2925720-B1 PROCESS FOR THE PREPARATION OF TRAVOPROST CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA ZRT (HU) 2019-05-22 EP claimed
EP-2723714-B1 NOVEL PROCESSES FOR THE PREPARATION OF PROSTAGLANDIN AMIDES CHINOIN ZRT (HU) 2017-06-21 EP claimed
EP-3087093-A1 PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES Stealth Biotherapeutics Corp (MC) 2016-11-02 EP claimed
EP-2828272-B1 CARBENE TRANSFER REAGENT UNIV JACOBS BREMEN GMBH (DE) 2016-10-19 EP claimed
WO-2015100376-A1 PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES STEALTH PEPTIDES INTERNATIONAL, INC. (MC) 2015-07-02 WO claimed
EP-1436284-B1 SYNTHESIS OF 4- (Z)-(4-BROMOPHENYL)(ETHOXYIMINO)METHYL]-1'- 2,4-DIMETHYL-1-OXIDO-3-PYRIDINYL)CARBONYL]-4'METHYL-1,4'BIPIPERIDINE SCHERING CORP (US) 2005-08-03 EP claimed
EP-0322765-B1 NEW THIAZOLIDINE DERIVATIVES, PROCESS FOR PREPARING SAME AND ANTI-AMNESTIC COMPOSITION CONTAINING SAME KABUSHIKI KAISHA YAKULT HONSHA (JP) 1993-08-04 EP claimed
US-12624011-B2 Oxadiazole derivative Sumitomo Pharma Co., Ltd. (JP) 2026-05-12 US disclosed
EP-4246147-B1 METHOD FOR MEASURING STEROL IN LIPOPROTEIN, AND REAGENT FOR MEASURING STEROL IN LIPOPROTEIN SYSMEX CORP (JP) 2026-05-06 EP disclosed
US-20260118757-A1 RADIATION-SENSITIVE RESIST COMPOSITION AND PATTERN FORMATION METHOD USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2026-04-30 US disclosed
US-20250376473-A1 PRMTS INHIBITOR AND USE THEREOF CYTOSINLAB THERAPEUTICS CO LTD (CN) 2025-12-11 US disclosed
EP-4660629-A1 METHOD FOR DETECTING TRANSTHYRETIN TETRAMER, AND METHOD FOR EVALUATING STABILITY SYSMEX CORPORATION (JP) 2025-12-10 EP disclosed
US-20020042521-A1 Nitrogen-based halogenating agents and process for preparing halogen-containing compounds SONODA HIROSHI (JP) 2002-04-11 US disclosed
US-6329529-B1 FOR FLUORINATING OF ORGANIC COMPOUNDS, EFFICIENCY, POLLUTION CONTROL MITSUI CHEMICALS, INC. (JP) 2001-12-11 US disclosed
EP-0895991-A2 Halogenating agent Mitsui Chemicals, Inc. (JP) 1999-02-10 EP disclosed
EP-0808839-A1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF, AND DRUGS CONTAINING THE SAME TAIHO PHARMACEUTICAL CO., LTD. (JP) 1997-11-26 EP disclosed
WO-1994007910-A1 NEW REAGENTS FOR PEPTIDE COUPLINGS RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1994-04-14 WO disclosed